Published in Eur J Pharm Biopharm on March 23, 2011
Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation. AAPS PharmSciTech (2013) 0.81
Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine. Int J Nanomedicine (2015) 0.76
Almost all about citrulline in mammals. Amino Acids (2005) 1.90
Mixture experiment methods in the development and optimization of microemulsion formulations. J Pharm Biomed Anal (2011) 1.51
Comparison between conventional axillary block and a new approach at the midhumeral level. Anesth Analg (1997) 1.50
Audit of ketoprofen prescribing after orthopedic and general surgery. Can J Anaesth (1999) 1.46
Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm (2004) 1.09
Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci (2013) 1.08
[Usefulness of biological markers in the evaluation of smoking at the first visit of a smoking cessation program]. Rev Mal Respir (2004) 1.07
Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide. J Pharm Biomed Anal (2002) 0.98
Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev Ind Pharm (1999) 0.93
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev Ind Pharm (2004) 0.91
Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Pharm Biopharm (2005) 0.91
Development of enteric-coated timed-release matrix tablets for colon targeting. J Drug Target (2004) 0.90
Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int J Pharm (2004) 0.89
Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins. Drug Dev Ind Pharm (2001) 0.86
Optimization of dissolution test precision for a ketoprofen oral extended-release product. J Pharm Biomed Anal (2003) 0.86
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques. J Pharm Biomed Anal (2005) 0.85
Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev Ind Pharm (2005) 0.85
New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm (2010) 0.84
Experimental design in the development of voltammetric method for the assay of omeprazole. J Pharm Biomed Anal (1996) 0.84
Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design. J Pharm Biomed Anal (2005) 0.84
Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature. Eur J Clin Pharmacol (2014) 0.83
Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. Eur J Pharm Sci (2008) 0.83
Physical characterization of picotamide monohydrate and anhydrous picotamide. J Pharm Sci (1999) 0.82
Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with alpha-cyclodextrin and glycine. J Pharm Sci (2003) 0.81
Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization. J Pharm Biomed Anal (2006) 0.81
Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. J Pharm Biomed Anal (2004) 0.81
Formulation and characterization of triclosan sub-micron emulsions and nanocapsules. J Microencapsul (2004) 0.81
How experimental design can improve the validation process. Studies in pharmaceutical analysis. Anal Bioanal Chem (2003) 0.81
Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Eur J Pharm Biopharm (2011) 0.80
Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. J Pharm Biomed Anal (2005) 0.80
Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. Eur J Pharm Biopharm (2011) 0.79
Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. Int J Pharm (2007) 0.78
Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution. J Pharm Sci (1991) 0.77
Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations. Eur J Pharm Sci (2008) 0.77
Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants. J Anal Toxicol (1998) 0.77
Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC. J Pharm Biomed Anal (2002) 0.77
Chlorophacinone intoxication. A biological and toxicological study. J Toxicol Clin Toxicol (1989) 0.76
Benzathine as a cause for a false-positive test result for amphetamines. J Pediatr (1995) 0.75
Acute cutaneous reactions induced by docetaxel: a case report. Therapie (2002) 0.75
Screening procedure for benzodiazepines in biological fluids by high-performance liquid chromatography using a rapid-scanning multichannel detector. J Chromatogr (1987) 0.75
[In vitro study on the changes in gastrointestinal absorption rate of drugs in the presence of various food components]. Farmaco Prat (1979) 0.75
Storage study on acidic aqueous hexetidine solutions in polyolefinic and glass containers. Boll Chim Farm (1980) 0.75
[The effect of pH on the in vitro absorption of diazepam]. Pharm Acta Helv (1987) 0.75
Determination of flubendazole in pharmaceutical dosage forms by differential pulse polarography and UV spectroscopy. Farmaco (1990) 0.75
Simultaneous determination of progabide and its acid metabolite by reversed-phase high-performance liquid chromatography. J Chromatogr (1990) 0.75
Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR). Met Based Drugs (2000) 0.75
1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with alpha-cyclodextrin in the presence of malic acid. J Pharm Biomed Anal (2000) 0.75
Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Farmaco (2005) 0.75
Precautions necessary when assaying aluminum in serum of chronic hemodialyzed patients. Clin Chem (1982) 0.75
Bioavailability and clinical usefulness of low-strength tablets of phenytoin. Farmaco Prat (1986) 0.75
[Assay of urinary iodides by specific electrodes: its value in dysthyroidism]. Ann Biol Clin (Paris) (1986) 0.75
Differential electrolytic potentiometry (DEP) with twin silver-silver sulphide membrane electrodes in micro titration of quaternary ammonium compounds. J Pharm Biomed Anal (1988) 0.75
Phase equilibria, crystallinity and dissolution rates of ibuprofen-polyethylene glycol 20000 solid dispersions. Farmaco Prat (1987) 0.75
Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery. Drug Dev Ind Pharm (2011) 0.75
Adsorptive stripping voltammetry for thiomersal assay. J Pharm Biomed Anal (1994) 0.75
[In vitro studies of the diffusion of acetylsalicylic acid from various suppository excipients]. Farmaco Prat (1980) 0.75
Differential pulse polarographic determination of thiomersal transported through an artificial membrane simulating an isolated rabbit cornea. Boll Chim Farm (1980) 0.75
Association of thymostimulin to antimycobacterial polychemotherapy in pulmonary tuberculosis. J Chemother (1989) 0.75
[In-vitro study on the diffusion velocity constants of p-2-(n-octyloxy)-benzoyl-aminobenzoate of N-diethylmethylammonioethyl bromide]. Boll Chim Farm (1976) 0.75
[Studies on the in vitro absorption of guaiacolylacetylsalicylate]. Farmaco Prat (1986) 0.75
[Removal of impacted teeth. Indications and contraindications]. Dent Cadmos (1990) 0.75
Determination of phenytoin in tablets by second-order derivative ultraviolet spectroscopy. Pharm Acta Helv (1987) 0.75
[Musculo-skeletal disorders and diseases in the complex metal-mechanical industry]. G Ital Med Lav Ergon (2006) 0.75
Zinc contamination of control serum. Clin Chem (1979) 0.75
Solid dispersions of ibuprofen in urea. Effects of urea on dissolution. Farmaco Prat (1986) 0.75
In vitro studies of simulated percutaneous absorption: influence of various enhancers in the release of clonazepam from 2-hydroxyethyl acetate patches. Pharm Acta Helv (1998) 0.75
Preparation and dissolution characteristics of solid dispersions of ibuprofen in various polyethylene glycols. Farmaco Prat (1987) 0.75
[Value of the assay of urinary neopterin in multiple myeloma. Preliminary study]. Rev Rhum Mal Osteoartic (1985) 0.75
Near-infrared reflectance spectrometry in the study of atopy. Part 2. Interactions between the skin and polyethylene glycol 400, isopropyl myristate and hydrogel. Analyst (1997) 0.75
[In vitro studies on the rates of intestinal absorption of sparsely soluble drugs of different particle size]. Boll Chim Farm (1980) 0.75
Interaction of naproxen with alpha-cyclodextrin and its noncyclic analog maltohexaose. Pharm Res (1999) 0.75
Formulation factors influencing the release of clonazepam from a carbopol hydrogel. Boll Chim Farm (1989) 0.75
XAS applied to pharmaceuticals: drug administration and bioavailability. J Synchrotron Radiat (2001) 0.75
Vitamin A concentrations in lung cancer. Clin Chem (1987) 0.75
Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations. J Pharm Biomed Anal (2006) 0.75
[Cephalometric study of skeletal-facial changes in oral respiration from obstruction]. Mondo Ortod (1990) 0.75
Development and validation of a differential pulse polarographic method for quinolinic acid determination in human plasma and urine after solid-phase extraction: a chemometric approach. J Pharm Biomed Anal (1998) 0.75
[Urinary neopterin: its value in the study of various neoplasms]. Ann Biol Clin (Paris) (1986) 0.75
Solubilization and interaction of naproxen with polyvinylpyrrolidone in aqueous solution and in the solid state. Farmaco Prat (1988) 0.75
Release of drugs in vitro from different dermatological preparations. Boll Chim Farm (1980) 0.75
Intoxication by benzodiazepines: studies with diazepam used as a model compound suggest an interaction with red blood cells calmodulin dependent (Ca2+, Mg2+) ATPase. Toxicol Lett (1983) 0.75
[New in vitro research in the field of corneal absorption by means of artificial membranes]. Farmaco Prat (1977) 0.75